Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

These health conditions contribute to a buildup of fat in the liver, experts say, which can then lead to fibrosis or scarring ...

Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...

Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin treatment were associated with improved PFS in ...

Pepto-Bismol (bismuth salicylate) and Tums (calcium carbonate) are both over-the-counter (OTC) medications for heartburn and ...

For years now, new soda brands have been popping up incessantly with every grocery store trip yields a fresh, ...

Is that evening glass of wine or weekend cocktail really harmless? Earlier this year, the U.S. Surgeon General issued an urgent advisory to raise awareness of the growing evidence linking alcohol ...

Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Mitolyn claims to be a nutritional weight loss supplement formulated to support a healthy weight and overall health, b ...